Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle (CZV_PAL1)
17. April 2017 aktualisiert von: Meng C. Lin, University of California, Berkeley
The purpose of this study was to compare objective clinical measures of visual performance and subjective measures of satisfaction and preference between standard progressive addition lens (PAL) spectacles and a new type of free-form surfaced, optically customized PAL spectacle.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Detaillierte Beschreibung
In a double-masked crossover trial, 95 experienced wearers wore customized free-form PAL spectacles (Test) and standard non-free-form PAL spectacles (Control) for one week each.
All subjects wore both Test and Control spectacles, and the pair to be worn first was randomly assigned.
At dispensing and after 1 week of wear, subjects were tested for distance and near visual acuity (VA) under both high and low contrast; in addition, 30 degree off-axis VA was measured using a novel apparatus, as was the horizontal extent of undistorted vision at reading distance.
Subjects also completed a set of questionnaires detailing their satisfaction levels, adaptation times, and preferences for Test or Control spectacles for different visual tasks.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
95
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
California
-
Berkeley, California, Vereinigte Staaten, 94720-2020
- Clinical Research Center, School of Optometry, University of California, Berkeley
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
39 Jahre bis 80 Jahre (Erwachsene, Älterer Erwachsener)
Akzeptiert gesunde Freiwillige
Ja
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Presbyope
- Experienced PAL spectacle wearer
- Correctable to at least 20/25 in both eyes
- Able and willing to use Test and Control spectacles for 1 week each as primary form of presbyopia correction
- Able and willing to complete all laboratory measurements and questionnaire batteries
Exclusion Criteria:
- Purchasing free-form PAL spectacles from the UC Berkeley Eyewear Center
- Having eye conditions or diseases that could potentially cause a decrease in visual acuity over the course of participation in the study
- Having eye conditions or diseases that could potentially interfere with ability to use Test and Control spectacles as primary form of presbyopia correction
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Randomized Order of Interventions 1
Randomized to first wear standard, non-free-form, non-customized PAL spectacles, then second, crossover to wear individually customized free-form surfaced PAL spectacles
|
Control spectacles include several different PAL brands as selected by patients in the UC Berkeley Optometry Clinic and purchased in the Eyewear Center; after successful fitting and purchase, potential subjects were recruited for the trial.
Test spectacles are Zeiss Individual, free-form surfaced, and customized using the iTerminal device to account for individual back vertex distance, wrap angle and pantoscopic tilt
Andere Namen:
|
|
Aktiver Komparator: Randomized Order of Interventions 2
Randomized to first wear individually customized free-form surfaced PAL spectacles, then second, crossover to wear standard, non-free-form, non-customized PAL spectacles
|
Control spectacles include several different PAL brands as selected by patients in the UC Berkeley Optometry Clinic and purchased in the Eyewear Center; after successful fitting and purchase, potential subjects were recruited for the trial.
Test spectacles are Zeiss Individual, free-form surfaced, and customized using the iTerminal device to account for individual back vertex distance, wrap angle and pantoscopic tilt
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Visual Acuity, High Contrast, Distance Chart
Zeitfenster: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of high contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Visual Acuity, Low Contrast, Distance Chart
Zeitfenster: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of low contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Visual Acuity, High Contrast, Near Chart
Zeitfenster: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of high contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Visual Acuity, Low Contrast, Near Chart
Zeitfenster: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of low contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
30-degree Off-axis Distance Visual Acuity, High Contrast Chart
Zeitfenster: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
30-degree Off-axis Distance Visual Acuity, Low Contrast Chart
Zeitfenster: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Horizontal Extent of Undistorted Vision at Reading Distance
Zeitfenster: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Novel apparatus designed to immobilize head and allow subject to indicate point of peripheral optical distortion on a modified Amsler-type grid
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Questionnaire Battery
Zeitfenster: At study exit, after both Test and Control spectacles had been worn for 1 week each
|
Forced-choice Likert scale preference questionnaire
|
At study exit, after both Test and Control spectacles had been worn for 1 week each
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Mitarbeiter
Ermittler
- Hauptermittler: Meng C. Lin, OD, PhD, Clinical Research Center, School of Optometry, University of California, Berkeley
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn
1. Februar 2009
Primärer Abschluss (Tatsächlich)
1. Oktober 2009
Studienabschluss (Tatsächlich)
1. Oktober 2009
Studienanmeldedaten
Zuerst eingereicht
3. November 2010
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
3. November 2010
Zuerst gepostet (Schätzen)
4. November 2010
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
18. April 2017
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
17. April 2017
Zuletzt verifiziert
1. April 2017
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- CZV_PAL1
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .